title: Prostate Cancer Screening - A Perspective on the Current State of the Evidence.
authors.affiliation: From the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.
authors.forename: Paul F
authors.initials: PF
authors.lastname: Pinsky
authors.affiliation: From the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.
authors.forename: Philip C
authors.initials: PC
authors.lastname: Prorok
authors.affiliation: From the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.
authors.forename: Barnett S
authors.initials: BS
authors.lastname: Kramer
mesh_terms: D003657:Decision Making; D055088:Early Detection of Cancer / Q000592:standards; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000592:standards; D016134:Organizational Policy; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy / Q000009:adverse effects; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy; D011878:Radiotherapy / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012955:Societies, Medical; D014481:United States
chemical_list: D017430:Prostate-Specific Antigen